| scholarly article | Q13442814 |
| P2093 | author name string | S M de la Monte | |
| J R Wands | |||
| N Ince | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | overexpression | Q61643320 |
| P304 | page(s) | 1261-6 | |
| P577 | publication date | 2000-03-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Overexpression of human aspartyl (asparaginyl) beta-hydroxylase is associated with malignant transformation | |
| P478 | volume | 60 |
| Q38712008 | A Radiolabeled Fully Human Antibody to Human Aspartyl (Asparaginyl) β-Hydroxylase Is a Promising Agent for Imaging and Therapy of Metastatic Breast Cancer |
| Q34250364 | A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma |
| Q35949450 | Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression. |
| Q91622958 | Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma |
| Q28201030 | Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) β-hydroxylase suppress migration of cholangiocarcinoma cells |
| Q57112122 | Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation |
| Q35176052 | Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype |
| Q98564461 | Aspartate β-hydroxylase as a target for cancer therapy |
| Q36723189 | Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma |
| Q92332826 | Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway |
| Q37485171 | Aspartate-β-hydroxylase (ASPH): A potential therapeutic target in human malignant gliomas |
| Q35157948 | Aspartyl-(asparaginyl) beta-hydroxylase, hypoxia-inducible factor-alpha and Notch cross-talk in regulating neuronal motility |
| Q56379222 | Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic Review |
| Q36001362 | Ceramide inhibitor myriocin restores insulin/insulin growth factor signaling for liver remodeling in experimental alcohol-related steatohepatitis |
| Q73315119 | Cholangiocarcinoma: preventing invasion as anti-cancer strategy |
| Q24655625 | Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival |
| Q33599455 | Development of a novel anti-human aspartyl-(asparaginyl) β-hydroxylase monoclonal antibody with diagnostic and therapeutic potential |
| Q94411866 | Differential Effects of 3rd Trimester-Equivalent Binge Ethanol and Tobacco-Specific Nitrosamine Ketone Exposures on Brain Insulin Signaling in Adolescence |
| Q33265938 | Differential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblastoma cells |
| Q47331366 | Ethanol-Induced White Matter Atrophy Is Associated with Impaired Expression of Aspartyl-Asparaginyl-β-Hydroxylase (ASPH) and Notch Signaling in an Experimental Rat Model |
| Q55378664 | Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway. |
| Q33874594 | Identification of a novel tumor transforming gene GAEC1 at 7q22 which encodes a nuclear protein and is frequently amplified and overexpressed in esophageal squamous cell carcinoma |
| Q35624314 | Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma |
| Q37216866 | Impaired placentation in fetal alcohol syndrome |
| Q89926103 | Kinetic parameters of human aspartate/asparagine-β-hydroxylase suggest that it has a possible function in oxygen sensing |
| Q42366399 | Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma |
| Q33897454 | Motor Function Deficits Following Chronic Prenatal Ethanol Exposure are Linked to Impairments in Insulin/IGF, Notch and Wnt Signaling in the Cerebellum |
| Q36495723 | Optimized Expression and Purification of Humbug in Pichia pastoris and Its Monoclonal Antibody Preparation |
| Q28246572 | Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver |
| Q53092252 | Phosphorylation Modulates Aspartyl-(Asparaginyl)-β Hydroxylase Protein Expression, Catalytic Activity and Migration in Human Immature Neuronal Cerebellar Cells. |
| Q41513131 | Potential Co-Factor Role of Tobacco Specific Nitrosamine Exposures in the Pathogenesis of Fetal Alcohol Spectrum Disorder |
| Q36170624 | Potential Role of Phosphorylation as a Regulator of Aspartyl-(asparaginyl)-β-hydroxylase: Relevance to Infiltrative Spread of Human Hepatocellular Carcinoma |
| Q35643230 | Precision-cut slice culture method for rat placenta |
| Q33944587 | Prognostic value of aspartyl (asparaginyl)-beta-hydroxylase/humbug expression in non-small cell lung carcinoma |
| Q90127696 | Prometastatic Secretome Trafficking via Exosomes Initiates Pancreatic Cancer Pulmonary Metastasis |
| Q59329484 | Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: A brief update |
| Q37679979 | Role of Notch signaling pathway in pancreatic cancer |
| Q47127142 | Tobacco Nitrosamine Exposures Contribute to Fetal Alcohol Spectrum Disorder Associated Cerebellar Dysgenesis |
| Q35894880 | Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma |
| Q33393444 | Upstream stimulatory factors are involved in the P1 promoter directed transcription of the A beta H-J-J locus |
| Q37023897 | siRNA inhibition of aspartyl-asparaginyl β-hydroxylase expression impairs cell motility, Notch signaling, and fetal growth |
Search more.